Biobeat is proud to take part in the 10th Annual Cardiovascular Disease Management Symposium on April 17, 2026.
As the use of ambulatory blood pressure monitoring ABPM and 24 hr blood pressure monitors continues to grow, clinicians are gaining better tools to detect masked hypertension in real world settings.
At the same time, traditional ABPM devices are being reimagined through innovations that allow for continuous blood pressure monitoring.
Our FDA cleared blood pressure monitor, designed as a wearable blood pressure monitoring patch, delivers a cuffless blood pressure solution that fits seamlessly into patients’ daily lives.
This cuffless blood pressure monitor operates as a continuous BP monitor, providing consistent, real time data that supports more proactive care.
We will be sharing how our FDA cleared, medical grade, validated cuffless blood pressure monitoring platform is changing the way hypertension is diagnosed and managed, for better patients experience and better outcomes.
We were especially inspired by the many healthcare leaders we met, all looking for ways to improve the healthcare ecosystem and patient outcomes through technology.
It is exciting to be part of a community so dedicated to advancing ambulatory BP monitoring and making a meaningful difference in care.
